338 related articles for article (PubMed ID: 33711310)
21. Cerebrovascular disease: Neuroimaging of cerebral small vessel disease.
Shaaban CE; Jorgensen DR; Gianaros PJ; Mettenburg J; Rosano C
Prog Mol Biol Transl Sci; 2019; 165():225-255. PubMed ID: 31481164
[TBL] [Abstract][Full Text] [Related]
22. Bone Morphogenic Protein 4 Mediates NOX1-Dependent eNOS Uncoupling, Endothelial Dysfunction, and COX2 Induction in Type 2 Diabetes Mellitus.
Youn JY; Zhou J; Cai H
Mol Endocrinol; 2015 Aug; 29(8):1123-33. PubMed ID: 26121233
[TBL] [Abstract][Full Text] [Related]
23. Emerging Role of Immunity in Cerebral Small Vessel Disease.
Fu Y; Yan Y
Front Immunol; 2018; 9():67. PubMed ID: 29422904
[TBL] [Abstract][Full Text] [Related]
24. Ambulatory blood pressure in patients with lacunar stroke: association with total MRI burden of cerebral small vessel disease.
Klarenbeek P; van Oostenbrugge RJ; Rouhl RP; Knottnerus IL; Staals J
Stroke; 2013 Nov; 44(11):2995-9. PubMed ID: 23982717
[TBL] [Abstract][Full Text] [Related]
25. Pathogenesis of white matter changes in cerebral small vessel diseases: beyond vessel-intrinsic mechanisms.
Joutel A; Chabriat H
Clin Sci (Lond); 2017 Apr; 131(8):635-651. PubMed ID: 28351960
[TBL] [Abstract][Full Text] [Related]
26. Impaired dynamic cerebral autoregulation is associated with the severity of neuroimaging features of cerebral small vessel disease.
Liu Z; Ma H; Guo ZN; Wang L; Qu Y; Fan L; Liu X; Liu J; Zhu Y; Yang Y
CNS Neurosci Ther; 2022 Feb; 28(2):298-306. PubMed ID: 34894087
[TBL] [Abstract][Full Text] [Related]
27. CNS small vessel disease: A clinical review.
Cannistraro RJ; Badi M; Eidelman BH; Dickson DW; Middlebrooks EH; Meschia JF
Neurology; 2019 Jun; 92(24):1146-1156. PubMed ID: 31142635
[TBL] [Abstract][Full Text] [Related]
28. Partial Endothelial Nitric Oxide Synthase Deficiency Exacerbates Cognitive Deficit and Amyloid Pathology in the APPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease.
Ahmed S; Jing Y; Mockett BG; Zhang H; Abraham WC; Liu P
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806318
[TBL] [Abstract][Full Text] [Related]
29. Epimedium flavonoids improve cognitive impairment and white matter lesions induced by chronic cerebral hypoperfusion through inhibiting the Lingo-1/Fyn/ROCK pathway and activating the BDNF/NRG1/PI3K pathway in rats.
Niu HM; Wang MY; Ma DL; Chen XP; Zhang L; Li YL; Zhang L; Li L
Brain Res; 2020 Sep; 1743():146902. PubMed ID: 32446949
[TBL] [Abstract][Full Text] [Related]
30. Exploring the Contribution of Myelin Content in Normal Appearing White Matter to Cognitive Outcomes in Cerebral Small Vessel Disease.
Dao E; Tam R; Hsiung GR; Ten Brinke L; Crockett R; Barha CK; Yoo Y; Al Keridy W; Doherty SH; Laule C; MacKay AL; Liu-Ambrose T
J Alzheimers Dis; 2021; 80(1):91-101. PubMed ID: 33523006
[TBL] [Abstract][Full Text] [Related]
31. Reversal of endothelial dysfunction reduces white matter vulnerability in cerebral small vessel disease in rats.
Rajani RM; Quick S; Ruigrok SR; Graham D; Harris SE; Verhaaren BFJ; Fornage M; Seshadri S; Atanur SS; Dominiczak AF; Smith C; Wardlaw JM; Williams A
Sci Transl Med; 2018 Jul; 10(448):. PubMed ID: 29973407
[TBL] [Abstract][Full Text] [Related]
32. Cell Senescence and Cerebral Small Vessel Disease in the Brains of People Aged 80 Years and Older.
Norton EJ; Bridges LR; Kenyon LC; Esiri MM; Bennett DC; Hainsworth AH
J Neuropathol Exp Neurol; 2019 Nov; 78(11):1066-1072. PubMed ID: 31553444
[TBL] [Abstract][Full Text] [Related]
33. Nicotinamide riboside rescues angiotensin II-induced cerebral small vessel disease in mice.
Li CC; Chen WX; Wang J; Xia M; Jia ZC; Guo C; Tang XQ; Li MX; Yin Y; Liu X; Feng H
CNS Neurosci Ther; 2020 Apr; 26(4):438-447. PubMed ID: 31943833
[TBL] [Abstract][Full Text] [Related]
34. S-Nitrosoglutathione Mimics the Beneficial Activity of Endothelial Nitric Oxide Synthase-Derived Nitric Oxide in a Mouse Model of Stroke.
Khan M; Dhammu TS; Qiao F; Kumar P; Singh AK; Singh I
J Stroke Cerebrovasc Dis; 2019 Dec; 28(12):104470. PubMed ID: 31680031
[TBL] [Abstract][Full Text] [Related]
35. Endothelial nitric oxide deficiency promotes Alzheimer's disease pathology.
Austin SA; Santhanam AV; Hinton DJ; Choi DS; Katusic ZS
J Neurochem; 2013 Dec; 127(5):691-700. PubMed ID: 23745722
[TBL] [Abstract][Full Text] [Related]
36. A Novel Rodent Model of Hypertensive Cerebral Small Vessel Disease with White Matter Hyperintensities and Peripheral Oxidative Stress.
Guy R; Volkman R; Wilczynski E; Yagil C; Yagil Y; Findler M; Auriel E; Nevo U; Offen D
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682594
[TBL] [Abstract][Full Text] [Related]
37. Pin1, endothelial nitric oxide synthase, and amyloid-β form a feedback signaling loop involved in the pathogenesis of Alzheimer's disease, hypertension, and cerebral amyloid angiopathy.
Wang JZ; Zhu WD; Xu ZX; Du WT; Zhang HY; Sun XW; Wang XH
Med Hypotheses; 2014 Feb; 82(2):145-50. PubMed ID: 24332564
[TBL] [Abstract][Full Text] [Related]
38. Pathophysiology of cerebral small vessel disease: a journey through recent discoveries.
Dupré N; Drieu A; Joutel A
J Clin Invest; 2024 May; 134(10):. PubMed ID: 38747292
[TBL] [Abstract][Full Text] [Related]
39. Altered neurovascular coupling and brain arginine metabolism in endothelial nitric oxide synthase deficient mice.
Hariharan A; Jing Y; Collie ND; Zhang H; Liu P
Nitric Oxide; 2019 Jun; 87():60-72. PubMed ID: 30877024
[TBL] [Abstract][Full Text] [Related]
40. Endothelial nitric oxide synthase regulates white matter changes via the BDNF/TrkB pathway after stroke in mice.
Cui X; Chopp M; Zacharek A; Ning R; Ding X; Roberts C; Chen J
PLoS One; 2013; 8(11):e80358. PubMed ID: 24236179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
